Call for Abstract

Euro Oncology Summit, will be organized around the theme “Fight Together For A Cancer Free World”

Euro Oncology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Oncology 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer is one of the leading cause of deaths across the world. Organ Specific Cancers are Cancers named basing on the site of Cancer in the body organ. Its incidence is showing an increasing tendency in various parts of the earth and has been a significant public health problem despite advances in the understanding of the molecular and cellular events that underlie. There are different types of Cancers based on location of cancer in the body organ. For example: Brain Cancer, Head and Neck Cancer, Oral Cancer, Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Gastric Cancer, Pancreatic Cancer, Kidney (Renal Cell) Cancer, Leukaemia etc. These types of Malignancies come under the category of Organ Specific Cancer.

  • Track 1-1Non-melanoma Skin Cancer
  • Track 1-2Breast Cancer
  • Track 1-3Lung Cancer
  • Track 1-4Prostate Cancer
  • Track 1-5Colorectal Cancer
  • Track 1-6Bladder Cancer
  • Track 1-7Endometrial Cancer
  • Track 1-8Non-Hodgkin lymphoma
  • Track 1-9And all other Organ specific Cancer....

The Epidemiology of Cancer is the study of the factors affecting Cancer, as a way to conclude possible trends and causes. The study of Cancer Epidemiology uses Epidemiological Methods to discover the cause of Cancer and to recognize and develop improved treatments. This area of study must cope with problems of lead time bias and length time bias. Lead time bias is the theory that early diagnosis may artificially inflate the survival statistics of a Cancer, without really improving the natural history of the disease. Length bias is the concept that gentler growing, more lethargic Tumors are more likely to be identified by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs

Prevention or Preventive Healthcare means measures that are taken for Cancer Prevention. Cancer can be prevented by living a healthy lifestyle. A healthy lifestyle and regular screening exams help to reduce your risk for some types of Cancer.

Screenings can find Cancer early, when it’s most treatable. Cancer Screening aims to identify Cancer before symptoms appear. This may involve blood tests, urine tests, other tests, or Medical Imaging. The benefits of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed against any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a specific age group. Selective Screening identifies people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Track 2-1Global trends in Cancer Mortality and Incidence
  • Track 2-2Cancer Epidemiological studies: Principles, Statistics, Methodologies & Reporting
  • Track 2-3Cancer Epidemiological Risk factors
  • Track 2-4Cancer Screening, evaluation and intervention
  • Track 2-5Early detection and diagnosis of Cancer
  • Track 2-6Cohort studies and Cancer Survival analysis
  • Track 2-7Cancer Staging

Cancer cells are the cells that divide continuously which flood the blood with abnormal cells and forms solid tumours. Cell division is a normal utilised by the body for growth and repair. A parent cell divides to form 2 daughter cells which are used to build a new tissue or to replace dead cells as a result of damage or ageing. Cancer Cells continue to produce copies where the healthy cells stop dividing as there is a no longer need for more daughter cells. Cancer Cells have capability of spreading from one part of the body to another in a process known as metastasis.

Carcinogenesis is also called as Tumorigenesis or Oncogenesis. It is the formation of cancer where the normal cells are transformed into the Cancer Cells. The process is characterized by changes in the abnormal cell division, cellular, genetic, and epigenetic levels. Cell division is a physiological procedure that occurs in all tissues. Normally the balance between proliferation and automatic cell death, in the form of Apoptosis, is maintained to ensure the consistency of tissues and organs.

Mutagenesis is a method by which the genetic information of an organism is altered, resulting in a mutation. DNA may be altered either naturally or artificially by using physical, chemical and biological agents which results in mutations. Mutagen generally changes the genetic material of DNA of an organism and increases the occurrence of mutation and increased level of Mutations cause Cancer. Some of the chemicals become mutagenic only through cellular processes and all the mutations are not caused by mutagens: “Spontaneous Mutations” occur due to hydrolysis, errors in DNA replication, repair and recombination.

  • Track 3-1Development of drugs that target multiple, distinct points in the cell cycle
  • Track 3-2Accompanying side effects caused by conventional chemotherapeutic agents
  • Track 3-3Biochemical mechanisms in relation to the cancer development
  • Track 3-4Mutations in the genes that encode cell cycle regulator proteins

Pathology is vital to Cancer diagnosis, treatment and research. Developments in pathology during the 20th century enabled more precise concepts to evolve and be adopted in clinical practice: cancer grading and staging, carcinoma in situ, Cytopathology in screening and diagnosis, immunohistochemistry and biomarkers. As we enter the 21st century, Cancer is acknowledged as a genetic disease that can be diagnosed and treated using molecular/genomic approaches in addition to traditional surgery, radiotherapy and chemotherapy. Another wave of technologic advances in digitization, telepathology, molecular diagnostics and genomic screening marks the latest paradigm shift in Cancer Pathology.

  • Track 4-1Promoting the adoption of modern techniques in Cancer Pathology
  • Track 4-2Preclinical and translational research, diagnostics and therapy
  • Track 4-3Tissue microarray construction in Cancer Pathology
  • Track 4-4Immunostaining, Digital image capture and analysis
  • Track 4-5Importance of Molecular alterations in development and progression in Cancer Pathology

Cancer is basically a disease of tissue growth regulation. In order for a normal cell to transform into a Cancer cell, the genes that regulate cell growth and differentiation must be altered. The affected genes are divided into two broad categories: Oncogenes and Tumor Suppressor Genes. Oncogenes are genes that stimulate cell growth and reproduction. Tumor Suppressor Genes are genes that inhibit cell division and survival. Malignant transformation can occur through the development of novel Oncogenes, the inappropriate over-expression of usual Oncogenes, or by the under-expression or disabling of Tumor Suppressor Genes. Typically, alterations in Multiple Genes are required to transform a normal cell into a Cancer cell.

Cancer Epigenetics deals with the Epigenetic Modifications to the genome of Cancer cells that do not involve any change in the nucleotide sequence. Epigenetic Alterations are as vital as Genetic Mutations in a normal cell transformation to Cancer cells, and their manipulation holds great promise for Cancer prevention, detection, and therapy. In different types of Cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of Tumor Suppressor Genes and activation of Oncogenes by altered CpG island methylation patterns, histone modifications, and dysregulation of DNA binding proteins. Several medications which have Epigenetic Impact are now used in several of these diseases.

  • Track 5-1Stem Cell Epigenome and Cancer
  • Track 5-2Epigenome Mapping
  • Track 5-3Role of Epigenetics and Genetics in Cancer Development
  • Track 5-4Genome-wide genetic and epigenetic analyses of Cancers
  • Track 5-5Epigenetic Therapy of Cancer
  • Track 5-6Epigenetic role for RNA in Cancer Development
  • Track 5-7Histone, miRNA and LncRNA Mediated cancer epigenetics
  • Track 5-8New Cancer epigenetic techniques

Cancer Immunology is a division of biology involved in understanding the role of the immune system in progression, advancement and the expansion of Cancer the most well recognized application is Cancer Immune Therapy, which uses the immune system as a treatment for Cancer.

Cancer Immunology interacts between the immune system and tumours or distortions.

Recognition of Cancer Specific Antigens

1. Immunosurveillance

  • Lymphocytes act as sentries in recognizing and eliminating continuously arising, nascent transformed cells

2. Immunoediting

I. Elimination

II. Equilibrium

III. Escape

  • Track 6-1Next Gen CAR-T Cell therapy
  • Track 6-2Novel concepts in Bispecific Antibodies Engineering
  • Track 6-3Pre-clinical and Translational Immuno-Oncology Developments
  • Track 6-4Check Point Inhibitors and Combination Strategies
  • Track 6-5Novel Payloads and Linkers
  • Track 6-6Oncolytic viruses in the era of checkpoint blockade
  • Track 6-7Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies

Targeted Cancer Therapy is one of the major modes of medical treatment for Cancer. Targeted Therapy blocks the growth of Cancer cells by interfering with Specific Targeted Molecules needed for carcinogenesis and tumor growth rather than by simply interfering with all rapidly dividing cells. Targeted Cancer Therapies are estimated to be more effective than older forms of treatments and less harmful to usual cells. Numerous Targeted Therapies are examples of immunotherapy using immune mechanisms for therapeutic aims developed by the field of cancer immunology. Therefore, as immunomodulators, they are one type of biological response modifiers.

  • Track 7-1Molecular targeted therapies
  • Track 7-2Types of targeted therapies: hormone therapies, signal transduction inhibitors, expression modulators, apoptosis inducers, angiogenesis inhibitors, toxin delivery molecules etc.
  • Track 7-3Pros and cons of Targeted Cancer Therapies
  • Track 7-4FDA approved Targeted Therapies for Cancer
  • Track 7-5Mechanisms of Targeted Cancer Therapies
  • Track 7-6Small molecule inhibitors in Cancer Therapy
  • Track 7-7Monoclonal Antibody-conjugated Nanoparticles for Targeted Cancer Therapy

Most Cancers are originally recognized either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which involves the examination of a tissue sample by a pathologist. People with suspected Cancer are examined with medical tests. These commonly include Blood Tests, CT Scans, X-rays and Endoscopy.

The Discovery and Development of Anticancer Drugs, especially cytotoxic agents, differ significantly from the Drug Development Process for any other indication. The unique challenges and opportunities in working with these agents are reflected in each stage of the Drug Development Process.

  • Track 8-1Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Track 8-2Novel blood-based Cancer Molecular Diagnostics
  • Track 8-3Liquid Biopsy, Pap test, Digital Rectal Exam (DRE), Biopsy, etc.
  • Track 8-4Genetic Testing, NGS and Sequencing
  • Track 8-5Microfluidic device for cancer screening

Radiation Therapy or Radiotherapy is done by using Ionization Radiation to treat Cancer by controlling or destroying malignant cells. Radiation Therapy may be therapeutic in various types of Cancer if they are localized to one area of the body. It can also be used as a part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a Primary Malignant Tumor. Radiation Therapy is synergistic with Chemotherapy, and has been used before, during, and after Chemotherapy in susceptible cancers. The subspecialty of Oncology concerned with Radiotherapy is called radiation Oncology.

Cancer Imaging is the term that covers many approaches used in diagnoses and Research Cancer. It is originally used to diagnose and stage the disease and now it is also used to assist with surgery and Radiotherapy, to identify patients who are responding to treatment and to look for early responses.

  • Track 9-1Endoscopy, Colonoscopy and Sigmoidoscopy
  • Track 9-2Imaging tests: X-ray, PET, CT, MRI, Mammography, ultrasound etc.
  • Track 9-3Nuclear medicine scans, bone scans, Fluoroscopy, SPECT and other methods

Cancer Biomarker is a process or a substance that is indicative of the presence of Cancer in the body. A Biomarker may be a molecule secreted by a tumor or specific response of the body to the presence of Cancer. Genetics, epigenetic, glycomic and Imaging Biomarkers can be utilized for the study of Cancer Transmission, conclusion and visualization. Generally such Biomarkers can be assayed in non-invasively collected bio fluids like serum and blood.

  • Track 10-1Biomarkers in Cancer diagnosis, prognosis, risk assessment, differential diagnosis and treatment
  • Track 10-2Clinical and Translational Biomarkers in Cancer Research
  • Track 10-3Immuno-oncology Biomarkers: Immune Profiling & Monitoring, Companion Diagnostics & Predictive Biomarkers
  • Track 10-4Cancer Biomarker discovery and validation
  • Track 10-5Digital Biomarkers: Biosensors, Wearable devices, and m-health applications
  • Track 10-6Biomarkers for Cancer patient screening
  • Track 10-7Cancer Biomarkers in Clinical Practice
  • Track 10-8Genetic biomarker and imaging Biomarkers in Cancer

Late logical advancements have helped in understanding the complex connection amongst Microbiome and Cancer. Our body is continuously exposed to Microbial Cells both resident and transient and their byproducts including toxic metabolites. Circulation of toxic metabolites leads to Cancer Progression to distant location from particular microbe resides and may migrate to other locations in the body and associates with Tumor development.

  • Track 11-1Microbiome in nutrition and metabolism
  • Track 11-2Microbiome: Interactions with the human environment
  • Track 11-3Moving microbiome research into human populations and beyond

An Oncology Nurse is a specialized nurse who cares for Cancer patients. Cancer patients take a long journey from diagnosis to treatment and beyond. Since cancer affects not only the body but also the psychological and social status of the patient in myriad ways, there is no single path taken by all Cancer patients. The journey is shared between the patient and Healthcare Professionals, and Nurses can provide both care and support to patients throughout their journey.

Palliative Care alludes to treatment that endeavours to enable the patient to feel better and might be joined with an attempt to treat the disease. Palliative Care incorporates activity to decrease physical, enthusiastic, otherworldly and psycho-social trouble.  Unlike treatment that is aimed specifically in destroying Cancer cells. The main objective of Palliative Care is to enhance personal satisfaction.

  • Track 12-1Facilitating Continuity of Care/Navigating the System
  • Track 12-2Health Promotion, Health Protection, Disease Prevention and Treatment
  • Track 12-3Monitoring and Ensuring the Quality of Healthcare Practice

A Cancer Vaccine is a vaccine that helps in treating existing Cancer or prevents its expansion. Vaccines that treat existing Cancer are known as Therapeutic Cancer Vaccines. Some/many of the Vaccines are "autologous", actually prepared from samples taken from the patient, and are specific to that patient. Some researchers claim that cancerous cells usually arise and are destroyed by the immune system and that Tumors form when the immune system fails to destroy them.

  • Track 13-1Autologous/allogeneic tumor cells as a tumor vaccine
  • Track 13-2Peptide-based vaccinations and Protein-based vaccines
  • Track 13-3DNA-based vaccines and Recombinant viruses as vaccine vectors
  • Track 13-4Some perspectives: prophylactic vaccinations and vaccinations in allogeneic bone marrow transplants

Gene Therapy deals with biomedical research with the objective of impacting the course of different hereditary and procured (alleged multi factorial) diseases at the DNA/RNA level. Cell treatment goes for focusing on different diseases at the cellular level, i.e. by re-establishing a specific cell populace or utilizing cells as therapeutic cargo. For most diseases, gene and cell therapy are applied in combination. Moreover, these two fields have given reagents, ideas, and techniques that are lighting up the better purposes of quality control, stem cell lineage, cell-cell interactions, input circles, enhancement circles, regenerative limit, and redesigning or remodelling.

  • Track 14-1Developed methods for isolating, expanding and engineering cancer-killing cells
  • Track 14-2Understanding of the genetic basis of cancer
  • Track 14-3Enhancing the immunogenicity of the tumor by introducing genes therapy

Metastasis is the process that permits some Cancer cells to break off from their Tumor of origin and take root in a different tissue. This is the main reason people die from Cancer. Currently, we have unmatched opportunities to unravel the biology of this problem, and a related one – the fact that some Tumors attain resistance to treatments over time. Our investigators pursue each aspect of research into Metastasis and Resistance, including Tumor Microenvironment Interactions, cell regulation, Cancer Stem Cells and more.

  • Track 15-1Analyzation of the ability of tumor subpopulations to acquire drug resistance
  • Track 15-2Tumorigenic and metastatic competence towards Drug Resistance
  • Track 15-3New linkages between metastasis and drug resistance

Clinical Trials are research studies that involve people. Clinical Trials are the finishing step in a long process that begins with research in a lab. Before any new treatment is used with people in Clinical Trials, researchers work for many years to understand its effects on Cancer cells in the lab and in animals. They also try to figure out the side effects it may cause. Trials are available for all stages of Cancer. It is a myth that they are only for people who have advanced Cancer that is not responding to treatment.

The Discovery and Development of Anticancer Drugs, especially cytotoxic agents, differ significantly from the Drug Development Process for any other indication. The unique challenges and opportunities in working with these agents are reflected in each stage of the Drug Development Process.

  • Track 16-1Advancements in Clinical Trials for Drug Development
  • Track 16-2Cancer Clinical trials data management
  • Track 16-3Cancer clinical trials case reports
  • Track 16-4Guidelines for Cancer Clinical trials
  • Track 16-5Cancer Clinical Trials protocol development
  • Track 16-6Preclinical and Clinical research for cancer therapies
  • Track 16-7Regulation of Cancer Drugs
  • Track 16-8Drug Discovery & Development
  • Track 16-9Pharmacovigilance aspects of Cancer drugs

The study of the Genetic Alterations of Tumor Suppressor Genes and Proto-Oncogenes in Solid Tumors has greatly increased our understanding of cancer biology.  Scientists are expanding our understanding of the fundamental processes by which Solid Tumors Develop, progress, and respond to treatment. Efforts span many research areas including cancer genetics and genomics, cell regulation and signalling, cancer metabolism, Tumor Microenvironment, animal models of cancer, and metastasis.

  • Track 17-1Treating a broad range of common and rare solid tumors
  • Track 17-2Well qualified and well-informed, evidence-based treatment plan
  • Track 17-3Randomized trials or in combination with other drugs
  • Track 17-4Identifying and validating novel high-throughput platforms of Solid Tumor Cancers

Complementary and Alternative are the terms that are used to describe many types of products, practices, and systems that are not part of mainstream medicine or standard care. Complementary and Alternative methods privilege to cure Cancer are nearly all unproven methods that are well proven to safely fight Cancer tend to be adopted into mainstream medicine fairly quickly.

  • Track 18-1Standard medicine with the Complementary and alternative Medicine (CAM) practices
  • Track 18-2CAM therapy approaches and research
  • Track 18-3Evaluation of regulatory issues and standard treatments
  • Track 18-4Claims and importance of Complementary and Alternative Medicine